Glycominds, LTD Patent applications |
Patent application number | Title | Published |
20110092383 | Method For Diagnosing Multiple Sclerosis - Disclosed is a method for diagnosing multiple sclerosis and more particularly to a method for diagnosing multiple sclerosis by measuring levels of antibodies to glycans in a biological sample. | 04-21-2011 |
20100254971 | Method for Diagnosing Prognosing Inflammatory Bowel Disease and Crohn's Disease - Disclosed are methods for diagnosing and prognosing Inflammatory Bowel disease or Crohn's disease (CD) by measuring levels of antibodies to glycans in a biological sample. | 10-07-2010 |
20100227337 | Method for Evaluating Risk in Multiple Sclerosis - The invention relates to methods and reagents for diagnosing and assessing the prognosis of multiple sclerosis. | 09-09-2010 |
20100159472 | Method for Diagnosing Multiple Sclerosis - Disclosed is a method for diagnosing and prognosing multiple sclerosis and more particularly to a method for diagnosing and prognosing multiple sclerosis by measuring levels of antibodies. The levels of IgM-type anti-Glc(α1,2)Glc(α) or Glc(α1,3)Glc(α) or Glc(α1,6)Glc(α) antibodies in serum act as diagnostic markers for MS disease and as prognostic biomarkers for the conversion of CIS patients suggestive of MS to clinically definite MS (CDMS) within 24 months. | 06-24-2010 |
20100099124 | Method for Diagnosing Diseases Based on Levels of Anti-Glycan Antibodies - Disclosed are methods for diagnosing Crohn's disease (CD) or anti-phospholipid syndrome by measuring levels of antibodies to glycans in a biological sample. | 04-22-2010 |
20100081160 | Method for Diagnosing Multiple Sclerosis - Disclosed is a method for diagnosing multiple sclerosis and more particularly to a method for diagnosing multiple sclerosis by measuring levels of antibodies to glycans in a biological sample. | 04-01-2010 |
20090291456 | Method for Diagnosing Multiple Sclerosis - Disclosed is a method for diagnosing multiple sclerosis and more particularly to a method for diagnosing multiple sclerosis by measuring levels of antibodies to glycans in a biological sample. | 11-26-2009 |